CAS: 2305154-31-6
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine REF: IN-DA01KK6JCAS: 2305154-31-6 | 97% | 108,00 €~216,00 € | Mar 07 Ene 25 | |
JCN037 REF: TM-T8431CAS: 2305154-31-6 | 99.50% | 39,00 €~537,00 € | Mar 14 Ene 25 | |
JCN037 REF: 3D-FSD15431CAS: 2305154-31-6 | Min. 95% | A consultar | Mar 18 Feb 25 |
N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine
CAS:2305154-31-6
Fórmula:
C16H11BrFN3O2
Pureza:
97%
Peso molecular:
376.1798
Ref: IN-DA01KK6J
25mg | 108,00 € | ||
50mg | 179,00 € | ||
100mg | 216,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
JCN037
CAS:2305154-31-6
JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of …
Fórmula:
C16H11BrFN3O2
Pureza:
99.50%
Forma y color:
Solid
Peso molecular:
376.18
Ref: TM-T8431
2mg | 39,00 € | ||
5mg | 72,00 € | ||
10mg | 102,00 € | ||
25mg | 172,00 € | ||
50mg | 263,00 € | ||
100mg | 377,00 € | ||
200mg | 537,00 € | ||
1mL*10mM (DMSO) | 81,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
JCN037
CAS:2305154-31-6
JCN037 is a potent, selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor in clinical …
Fórmula:
C16H11BrFN3O2
Pureza:
Min. 95%
Peso molecular:
376.18 g/mol
Ref: 3D-FSD15431
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025